Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)

The Y-AIDA study was designed to investigate the renal- and home blood pressure (BP)-modulating effects of add-on dapagliflozin treatment in Japanese individuals with type 2 diabetes mellitus (T2DM) and albuminuria. We conducted a prospective, multicenter, single-arm study. Eighty-six patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular Diabetology 2019-08, Vol.18 (1), p.110-16, Article 110
Hauptverfasser: Kinguchi, Sho, Wakui, Hiromichi, Ito, Yuzuru, Kondo, Yoshinobu, Azushima, Kengo, Osada, Uru, Yamakawa, Tadashi, Iwamoto, Tamio, Yutoh, Jun, Misumi, Toshihiro, Aoki, Kazutaka, Yasuda, Gen, Yoshii, Taishi, Yamada, Takayuki, Ono, Syuji, Shibasaki-Kurita, Tomoko, Hosokawa, Saho, Orime, Kazuki, Hanaoka, Masaaki, Sasaki, Hiroto, Inazumi, Kohji, Yamada, Taku, Kobayashi, Ryu, Ohki, Kohji, Haruhara, Kotaro, Kobayashi, Yusuke, Yamanaka, Takeharu, Terauchi, Yasuo, Tamura, Kouichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Y-AIDA study was designed to investigate the renal- and home blood pressure (BP)-modulating effects of add-on dapagliflozin treatment in Japanese individuals with type 2 diabetes mellitus (T2DM) and albuminuria. We conducted a prospective, multicenter, single-arm study. Eighty-six patients with T2DM, HbA1c 7.0-10.0%, estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73 m , and urine albumin-to-creatinine ratio (UACR) ≥ 30 mg/g creatinine (gCr) were enrolled, and 85 of these patients were administered add-on dapagliflozin for 24 weeks. The primary and key secondary endpoints were change from baseline in the natural logarithm of UACR over 24 weeks and change in home BP profile at week 24. Baseline median UACR was 181.5 mg/gCr (interquartile range 47.85, 638.0). Baseline morning, evening, and nocturnal home systolic/diastolic BP was 137.6/82.7 mmHg, 136.1/79.3 mmHg, and 125.4/74.1 mmHg, respectively. After 24 weeks, the logarithm of UACR decreased by 0.37 ± 0.73 (P 
ISSN:1475-2840
1475-2840
DOI:10.1186/s12933-019-0912-3